Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL17076872 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| SCHEMBL27917257 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| SCHEMBL3156871 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| SCHEMBL15189290 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| SCHEMBL4894065 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| SCHEMBL6065522 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| Heptane SCHEMBL17076924 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| Heptane SCHEMBL17076906 | 0.97 | TSHR (0.44) | OPRM1LMNATP53DNM1TSHR | |
| Phosphine SCHEMBL19411938 | 0.95 | LMNA (0.42) | OPRM1LMNATP53DNM1TSHR | |
| Ammonia Solution, Strong SCHEMBL7229632 | 0.95 | LMNA (0.42) | OPRM1LMNATP53DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11583833-B2 | Calcium salts-supported metal catalyst, method for preparing the same, and method for hydrodeoxygenation reaction of oxygenates using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-02-21 | — | — | US | claimed |
| US-20210162376-A1 | CALCIUM SALTS-SUPPORTED METAL CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR HYDRODEOXYGENATION REACTION OF OXYGENATES USING THE SAME | KOREA INST SCI & TECH (KR) | 2021-06-03 | — | — | US | claimed |
| US-11583833-B2 | Calcium salts-supported metal catalyst, method for preparing the same, and method for hydrodeoxygenation reaction of oxygenates using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-02-21 | — | — | US | disclosed |
| US-20210162376-A1 | CALCIUM SALTS-SUPPORTED METAL CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR HYDRODEOXYGENATION REACTION OF OXYGENATES USING THE SAME | KOREA INST SCI & TECH (KR) | 2021-06-03 | — | — | US | disclosed |
| US-10953387-B2 | Calcium salts-supported metal catalyst, method for preparing the same, and method for hydrodeoxygenation reaction of oxygenates using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20190381484-A1 | CALCIUM SALTS-SUPPORTED METAL CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR HYDRODEOXYGENATION REACTION OF OXYGENATES USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2019-12-19 | — | — | US | disclosed |
| US-7678929-B2 | Furochroman derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-03-16 | — | — | US | disclosed |
| US-20080177095-A1 | FUROCHROMAN DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| US-4451654-A | Conditioning of finely divided crude organic pigments | BASF AKTIENGESELLSCHAFT (DE) | 1984-05-29 | — | — | US | disclosed |
| US-4153809-A | TRIHYDROCARBYLPHOSPHINE OXIDE AS THE EXTRACTION AGENT | CHEVRON RESEARCH COMPANY (US) | 1979-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177095-A1 | FUROCHROMAN DERIVATIVES | CFD, LMAN1, UROD | OPRM1 506/4885LMNA 1056/4885TP53 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.